[1] |
Falkinham JO 3rd . Current epidemiologic trends of the nontuberculous mycobacteria(NTM)[J]. Curr Environ Health Rep, 2016,3(2):161-167.DOI: 10.1007/s40572-016-0086-z.
doi: 10.1007/s40572-016-0086-z
pmid: 27020801
|
[2] |
Henkle E, Winthrop KL . Nontuberculous mycobacteria infections in immunosuppressed hosts[J]. Clin Chest Med, 2015,36(1):91-99.DOI: 10.1016/j.ccm.2014.11.002.
doi: 10.1016/j.ccm.2014.11.002
pmid: 4710582
|
[3] |
Diel R, Jacob J, Lampenius N , et al. Burden of non-tuberculous mycobacterial pulmonary disease in Germany[J]. Eur Respir J, 2017,49(4):1602109.DOI: 10.1016/j.jval.2016.09.1185.
doi: 10.1016/j.jval.2016.09.1185
|
[4] |
Myneedu VP, Verma AK, Bhalla M , et al, Occurrence of nontuberculous mycobacterium in clinical samples-a potential pathogen[J]. Indian J Tuberc, 2013,60(2):71-76.DOI: 10.1001/archinte.150.3.694.
doi: 10.1001/archinte.150.3.694
|
[5] |
Nunescosta D, Alarico S, Dalcolmo MP , et al. The looming tide of nontuberculous mycobacterial infections in Portugal and Brazil[J]. Tuberculosis, 2016,96(1):107-119.DOI: 10.1016/j.tube.2015.09.006.
doi: 10.1016/j.tube.2015.09.006
|
[6] |
Donohue MJ . Increasing nontuberculous mycobacteria reporting rates and species diversity identified in clinical laboratory reports[J]. BMC Infect Dis, 2018,18(1):163.DOI: 10.1186/s12879-018-3043-7.
doi: 10.1186/s12879-018-3043-7
|
[7] |
World Health Organization. Global tuberculosis report 2018[R]. Geneva:World Health Organization, 2018.
|
[8] |
Wang L, Zhang H, Ruan Y , et al. Tuberculosis prevalence in China,1990-2010;a longitudinal analysis of national survey data[J]. Lancet, 2014,383(9934):2057-2064.DOI: 10.1016/S0140-6736(13)62639-2.
doi: 10.1016/S0140-6736(13)62639-2
|
[9] |
Xu HB, Jiang RH, Li L . Treatment outcomes for mycobacterium avium complex:a systematic review and meta-analysis[J]. Eur J Clin Microbiol Infect Dis, 2014,33(3):347-348.DOI: 10.1007/s10096-013-1962-1.
doi: 10.1007/s10096-013-1962-1
|
[10] |
Brode SK, Marchand-Austin A, Jamieson FB , et al. Pulmonary versus nonpulmonary nontuberculous mycobacteria,Ontario,Canada[J]. Emerg Infect Dis, 2017,23(11):1898-1901.DOI: 10.3201/eid2311.170959.
doi: 10.3201/eid2311.170959
pmid: 29048292
|
[11] |
Henkle E, Hedberg K, Schafer SD , et al. Surveillance of extrapulmonary nontuberculous mycobacteria infections,Oregon,USA,2007-2012[J]. Emerg Infect Dis, 2017,23(10):1627-1630.DOI: 10.3201/eid2310.170845.
doi: 10.3201/eid2310.170845
|
[12] |
Smith GS, Ghio AJ, Stout JE , et al. Epidemiology of nontuberculous mycobacteria isolations among central North Carolina residents,2006-2010[J]. J Infect, 2016,72(6):678-686.DOI: 10.1016/j.jinf.2016.03.008.
doi: 10.1016/j.jinf.2016.03.008
|
[13] |
Dos Santos RP, Scheid K, Goldani LZ . Disseminated nontuberculous mycobacterial disease in patients with acquired immune deficiency syndrome in the South of Brazil[J]. Trop Doct, 2010,40(4):211-213.DOI: 10.1258/td.2010.100019.
doi: 10.1258/td.2010.100019
pmid: 20643867
|
[14] |
Kobayashi T, Nishijima T, Teruya K , et al. High mortality of disseminated non-tuberculous mycobacterial infection in HIV-infected patients in the antiretroviral therapy era[J]. PLoS One, 2016,11(3):e0151682.DOI: 10.1371/journal.pone.0151682.
doi: 10.1371/journal.pone.0151682
pmid: 4795669
|
[15] |
Ristola MA, von Reyn CF, Arbeit RD , et al. High rates of disseminated infection due to non-tuberculous mycobacteria among AIDS patients in Finland[J]. J Infection, 1999,39(1):61-67.DOI: 10.1016/S0163-4453(99)90104-4.
doi: 10.1016/S0163-4453(99)90104-4
|
[16] |
Patsche CB, Svensson E, Wejse C . Disseminated mycobacterium celatum disease with prolonged pulmonary involvement[J]. J Infect Dis, 2014,26(1):88-90.DOI: 10.1016/j.ijid.2014.02.020.
doi: 10.1016/j.ijid.2014.02.020
pmid: 25008771
|
[17] |
Chavarria M, Lutwick L, Dickinson BL . TB or not TB? Mycobacterium celatum mimicking mycobacterium tuberculosis:a case of mistaken identity[J]. ID Cases, 2018,11(1):83-87.DOI: 10.1016/j.idcr.2018.01.015.
doi: 10.1016/j.idcr.2018.01.015
|
[18] |
Asakura T, Namkoong H, Sakagami T , et al. Disseminated mycobacterium genavense infection in patient with adult-onset immunodeficiency[J]. Emerg Infect Dis, 2017,23(7):1208-1210.DOI: 10.3201/eid2307.161677.
doi: 10.3201/eid2307.161677
pmid: 28628454
|
[19] |
Numbi N, Demeure F, Van BP , et al. Disseminated mycobacterium genavense infection in a patient with immunosuppressive therapy and lymphoproliferative malignancy[J]. Acta Clinica Belgica, 2014,69(2):142-145.DOI: 10.1179/0001551213Z.00000000016.
doi: 10.1179/0001551213Z.00000000016
pmid: 24724760
|
[20] |
Shaharir SS, Sahari NS, Fuad ZM , et al. Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus(SLE)patient:a case review and pooled case analysis[J]. Clin Rheumatol, 2018,37(3):837-847.DOI: 10.1007/s10067-017-3855-7.
doi: 10.1007/s10067-017-3855-7
|
[21] |
Lai CC, Lee LN, Ding LW , et al. Emergence of disseminated infections due tonontuberculous mycobacteria in non-HIV-infected patients,including immunocompetent and immunocompromised patients in an university hospital in Taiwan[J]. J Infection, 2006,53(2):77-84.DOI: 10.1016/j.jinf.2005.10.009.
doi: 10.1016/j.jinf.2005.10.009
|
[22] |
Bian SN, Zhang LF, Zhang YQ , et al. Clinical and laboratory characteristics of patients with nontuberculous mycobacterium bloodstream infection in a tertiary referral hospital in Beijing,China[J]. Chinese Med J, 2016,129(18):2220-2225.DOI: 10.4103/0366-6999.189920.
doi: 10.4103/0366-6999.189920
|
[23] |
Griffith DE, Aksamit T, Brown-Elliott BA , et al. An official ATS/IDSA statement:diagnosis,treatment,and prevention of nontuberculous mycobacterial diseases[J]. Am J Respir Crit Care Med, 2007,175(4):367-416.DOI: 10.1164/rccm.200604-571ST.
doi: 10.1164/rccm.200604-571ST
|
[24] |
中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗专家共识[J]. 中华结核和呼吸杂志, 2012,35(8):572-580.DOI: 10.3760/cma.j.issn.1001-0939.2012.08.006.
doi: 10.3760/cma.j.issn.1001-0939.2012.08.006
|
[25] |
Hoefsloot W, van Ingen J, Peters EJG , et al. Mycobacterium genavense in the Netherlands:an opportunistic pathogenin HIV and non-HIV immunocompromised patients.An observational study in 14 cases[J]. Clin Microbiol Infect, 2013,19(5):432-437.DOI: 10.1111/j.1469-0691.2012.03817.x.
doi: 10.1111/j.1469-0691.2012.03817.x
pmid: 22439918
|
[26] |
Yamamoto Y, Yasuoka A, Tachikawa N , et al. Two cases of long lasting bacteremia due to mycobacterium avium complex despite new macrolides-containing regimens in patients with acquired immunodeficiency syndrome[J]. Intern Med, 2001,40(5):454-458.DOI: 10.2169/internalmedicine.40.454.
doi: 10.2169/internalmedicine.40.454
|
[27] |
Hashemi-Shahraki A, Heidarieh P, Khosravi AD , et al. Mycobacterium arupense infection in HIV-infected patients from Iran[J]. Int J STD AIDS, 2013,24(6):485-487.DOI: 10.1177/0956462412472818.
doi: 10.1177/0956462412472818
pmid: 23970753
|
[28] |
Narang R, Narang P, Jain AP , et al. Mycobacterium avium bacteremia and dual infection with Mycobacterium avium and mycobacterium wolinskyi in the gut of an AIDS patient-First case report[J]. Indian J Tuberc, 2010,57(3):148-151.DOI: 10.1016/j.polymdegradstab.2009.04.026.
doi: 10.1016/j.polymdegradstab.2009.04.026
pmid: 21043313
|
[29] |
Lins L, Farias é, Brites-Alves C , et al. Increased expression of CD38 and HLADR in HIV-infected patients with oral lesion[J]. J Med Virol, 2017,89(10):1782-1787.DOI: 10.1002/jmv.24852.
doi: 10.1002/jmv.24852
|
[30] |
谢静, 王焕玲, 邱志峰 , 等. 成人传染性单核细胞增多症和慢性活动性EB病毒感染外周血淋巴细胞亚群分析[J]. 中华内科杂志, 2016,55(6):455-459.DOI: 10.3760/cma.j.issn.0578-1426.2016.06.011.
doi: 10.3760/cma.j.issn.0578-1426.2016.06.011
|
[31] |
Gómez-Mora E, Massanella M, García E , et al. Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery[J]. PLoS One, 2017,12(9):e0184433.DOI: 10.1371/journal.pone.0184433.
doi: 10.1371/journal.pone.0184433
pmid: 28934217
|